المؤلفون: Dennis J. Slamon, Thomas Bachelot, Erik Jakobsen, Rashmi Krishna Murthy, Alicia Okines, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Ian E. Krop, Karen A. Gelmon, Volkmar Müller, Nan Lin, Virginia F. Borges, Eric P. Winer, Gabriel N. Hortobagyi, Philippe L. Bedard, Richard Greil, Sara A. Hurvitz, François Duhoux, Luke Walker, Sofia Braga, Elisavet Paplomata, M Corinna Palanca-Wessels, Sherene Loi, Vandana G. Abramson, Mafalda Oliveira, Carey K. Anders, Wentao Feng, Mark D. Pegram, Shlomit S. Shachar, Sibylle Loibl, Erika Hamilton

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: K Murthy, R, Loi, S, Okines, A, Paplomata, E, Hamilton, E, A. Hurvitz, S, U. Lin, N, Borges, V, Abramson, V, Anders, C, L. Bedard, P, Oliveira, M, Jakobsen, E, Bachelot, T, S. Shachar, S, Müller, V, Braga, S, P. Duhoux, F, Greil, R, Cameron, D, A. Carey, L, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & P. Winer, E 2020, ' Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
The New England journal of medicine, Vol. 382, no. 7, p. 597-609 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Protein-Tyrosine Kinases/antagonists & inhibitors, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Trastuzumab/administration & dosage, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Breast Neoplasms/drug therapy, Double-Blind Method, Trastuzumab, Internal medicine, medicine, Humans, 030212 general & internal medicine, Progression-free survival, skin and connective tissue diseases, neoplasms, Human Epidermal Growth Factor Receptor 2, Aged, integumentary system, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Disease progression, Consolidation Chemotherapy, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Progression-Free Survival, Multicenter study, Capecitabine/administration & dosage, Receptor, ErbB-2/analysis, Brain Neoplasms/secondary, Diarrhea/chemically induced, Female, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5309a1bc026281d5d475def4ba6ca36
https://www.pure.ed.ac.uk/ws/files/125147047/NEJMoa1914609.pdf

المؤلفون: Alice T. Shaw, Shirish M. Gadgeel, Solange Peters, S-H.I. Ou, Silvia Novello, Ali Zeaiter, Maurice Pérol, Anna Wrona, D.R. Camidge, Dong Wan Kim, Bogdana Balas, Eveline Nüesch, Ting Liu, Tony Mok, Rafael Rosell

المصدر: Annals of oncology, vol. 29, no. 11, pp. 2214-2222

مصطلحات موضوعية: 0301 basic medicine, Alectinib, Oncology, Male, Adult, Aged, Aged, 80 and over, Anaplastic Lymphoma Kinase/antagonists & inhibitors, Anaplastic Lymphoma Kinase/genetics, Brain/diagnostic imaging, Brain/drug effects, Brain/radiation effects, Brain Neoplasms/diagnostic imaging, Brain Neoplasms/genetics, Brain Neoplasms/secondary, Brain Neoplasms/therapy, Carbazoles/pharmacology, Carbazoles/therapeutic use, Carcinoma, Non-Small-Cell Lung/diagnostic imaging, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/secondary, Carcinoma, Non-Small-Cell Lung/therapy, Chemoradiotherapy/methods, Crizotinib/pharmacology, Crizotinib/therapeutic use, Disease Progression, Female, Humans, Lung/diagnostic imaging, Lung/drug effects, Lung/radiation effects, Lung Neoplasms/diagnostic imaging, Lung Neoplasms/genetics, Lung Neoplasms/pathology, Lung Neoplasms/therapy, Magnetic Resonance Imaging, Middle Aged, Piperidines/pharmacology, Piperidines/therapeutic use, Treatment Outcome, Tumor Burden/drug effects, Tumor Burden/radiation effects, Young Adult, Lung Neoplasms, ALK+, medicine.medical_treatment, 0302 clinical medicine, Piperidines, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Lung, Brain Neoplasms, Hazard ratio, Brain, Hematology, Chemoradiotherapy, Tumor Burden, 030220 oncology & carcinogenesis, CNS, medicine.drug, medicine.medical_specialty, Carbazoles, 03 medical and health sciences, Crizotinib, Internal medicine, medicine, Carcinoma, Lung cancer, non-small-cell lung cancer, business.industry, medicine.disease, Radiation therapy, 030104 developmental biology, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202d9467b40c9c8632a07affb6261137
https://pubmed.ncbi.nlm.nih.gov/30239586

المؤلفون: Lee D. Cranmer, Sigrun Hallmeyer, Rene Gonzalez, Anna C. Pavlick, John D. Hainsworth, F. Stephen Hodi, Lynn M. Schuchter, Bann Mo Day, C. Lance Cowey, David F. McDermott, David H. Lawson, R. Linke, Fred J. Kudrik, Brendan D. Curti, Paul B. Chapman, Kim Margolin, Keith T. Flaherty, Omid Hamid, Gerald P. Linette, Antoni Ribas, Lawrence E. Flaherty

المصدر: Cancer journal (Sudbury, Mass.), vol 20, iss 1

مصطلحات موضوعية: Oncology, Male, Cancer Research, Skin Neoplasms, Indoles, medicine.medical_treatment, neoplasm metastasis/drug therapy, Melanoma/drug therapy, Neoplasm Metastasis, Vemurafenib, Melanoma, Cancer, education.field_of_study, Sulfonamides, clinical trial, Middle Aged, brain neoplasms/drug therapy, melanoma/genetics, Female, Patient Safety, medicine.drug, medicine.medical_specialty, Population, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Ipilimumab, QT interval, Clinical Research, Internal medicine, medicine, BRAF protein, Humans, human, Oncology & Carcinogenesis, education, Adverse effect, brain neoplasms/secondary, business.industry, Neurosciences, vemurafenib/adverse effects, medicine.disease, vemurafenib/therapeutic use, Dermatology, United States, Clinical trial, Radiation therapy, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3953e48760c3f30385fbbce2f234de
https://escholarship.org/uc/item/6jv605j1

المؤلفون: Curzio Rüegg, Solange Peters

المصدر: Journal of the National Cancer Institute, vol. 101, no. 15, pp. 1034-1035

مصطلحات موضوعية: Oncology, Tumor angiogenesis, Double-Blind, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Disease, Growth, Maintenance Therapy, Maintenance therapy, Internal medicine, medicine, Chemotherapy, Multiple myeloma, business.industry, medicine.disease, Phase-Ii Trial, Angiogenesis Inhibitors/administration & dosage, Angiogenesis Inhibitors/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Brain Neoplasms/prevention & control, Brain Neoplasms/secondary, Clinical Trials, Phase III as Topic, Cranial Irradiation, Humans, Lung Neoplasms/drug therapy, Neoplasm Recurrence, Local/prevention & control, Radiotherapy, Adjuvant, Randomized Controlled Trials as Topic, Small Cell Lung Carcinoma/drug therapy, Small Cell Lung Carcinoma/prevention & control, Thalidomide/administration & dosage, Thalidomide/therapeutic use, Treatment Failure, Treatment Outcome, Tumor Markers, Biological/metabolism, Thalidomide, Clinical trial, Radiation therapy, Tumor Angiogenesis, Multiple-Myeloma, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc462ed36719c683a6c074d094437dc7
https://infoscience.epfl.ch/record/159544